Arrowhead Research Corporation (Nasdaq: ARWR) announced the acquisition of Novartis’ (NYSE: NVS) entire RNAi research and development portfolio and associated ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE